320 related articles for article (PubMed ID: 26394686)
1. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
2. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Albiñana V; Escribano RMJ; Soler I; Padial LR; Recio-Poveda L; Villar Gómez de Las Heras K; Botella LM
Orphanet J Rare Dis; 2017 Jun; 12(1):122. PubMed ID: 28662711
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
4. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
5. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM
Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894
[TBL] [Abstract][Full Text] [Related]
6. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
7. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
[TBL] [Abstract][Full Text] [Related]
8. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
13. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
15. Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease.
Shepard MJ; Bugarini A; Edwards NA; Lu J; Zhang Q; Wu T; Zhuang Z; Chittiboina P
J Neurosurg; 2018 Oct; 131(4):1106-1114. PubMed ID: 30497198
[TBL] [Abstract][Full Text] [Related]
16. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.
Sizdahkhani S; Feldman MJ; Piazza MG; Ksendzovsky A; Edwards NA; Ray-Chaudhury A; Maric D; Merrill MJ; Pacak K; Zhuang Z; Chittiboina P
Sci Rep; 2017 Jan; 7():40822. PubMed ID: 28094316
[TBL] [Abstract][Full Text] [Related]
18. Von Hippel-Lindau disease.
Chittiboina P; Lonser RR
Handb Clin Neurol; 2015; 132():139-56. PubMed ID: 26564077
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
[TBL] [Abstract][Full Text] [Related]
20. Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease.
Gläsker S; Klingler JH; Müller K; Würtenberger C; Hader C; Zentner J; Neumann HP; Velthoven VV
Cent Eur Neurosurg; 2010 May; 71(2):80-7. PubMed ID: 20229452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
